In Depth

Asian countries prioritise rare disease market access amid stark disparities

Supercritical fluids advance sterilisation tech in pharma

Fighting AMR with a value and subscription model

Q&A: How can the US maintain access to essential drugs?

Inflation reduction act boosts biologic VC financing over small molecules